July 2023

GLP-1 medication mania… the good, the bad and the ugly

GLP-1 medication mania… the good, the bad and the ugly

Hello everyone, I trust this missive finds you in good spirits whilst taking full advantage of the weekend respite. Despite the ongoing weather pattern of intense / unstable atmospheric conditions, heat and an almost tropical level of humidity, we’ve nonetheless managed to enjoy some quality outdoor time across the twenty30 team. And today is offering […]

GLP-1 medication mania… the good, the bad and the ugly Read More »

The WeightWatchers gamble; employers crackdown on GLP-1s; patients sabotaged by their own physicians; and racism and obesity in our adolescents.

The WeightWatchers gamble; employers crackdown on GLP-1s; patients sabotaged by their own physicians; and racism and obesity in our adolescents.

Hello everyone, I hope you are enjoying this weekend!  It has been a week of sunshine — and heat! And humidity, and allergies, in the Northeast this week. It was also a week where we were able to convene our growing twenty30health team in Philadelphia, the cradle of so much emerging healthcare innovation. What a

The WeightWatchers gamble; employers crackdown on GLP-1s; patients sabotaged by their own physicians; and racism and obesity in our adolescents. Read More »

Access, affordability and adherence issues with GLP-1 meds; outcomes beyond weight loss to enhance cardiovascular health; AI for obesity management

Access, affordability and adherence issues with GLP-1 meds; outcomes beyond weight loss to enhance cardiovascular health; AI for obesity management?

Hello everyone, I hope you are enjoying the weekend, and trust you enjoyed the fireworks, summer sunshine and celebrations of American Independence Day this past week. It was a slower news week in the obesity management space, perhaps a function of summer vacations — we are taking ours’ this week — but the growing focus

Access, affordability and adherence issues with GLP-1 meds; outcomes beyond weight loss to enhance cardiovascular health; AI for obesity management? Read More »

The Golden Age of Medicine; GLP-1 drugs are “having a moment…”; impressive data from trials; and multimodal approaches to align with surgical therapies.

Hello everyone, I hope you are enjoying the weekend, staying clear of wildfire smoke, and preparing for July 4th: Happy Independence Day! (And, it must be said, my condolences to my fellow Brits!). This has been quite a week on the obesity treatment front, with a ton on new drugs in the pipeline announced and

The Golden Age of Medicine; GLP-1 drugs are “having a moment…”; impressive data from trials; and multimodal approaches to align with surgical therapies. Read More »

Scroll to Top
Skip to content